The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.A review of the device history record has been completed. no deviations or non-conformances identified.This is a known potential adverse event addressed in the product labeling.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.
|
Healthcare professional (hcp) reported injecting a patient with 2ml of juvéderm voluma® xc in the cheeks and 0.4ml of juvéderm volbella® xc in the lips.About 6 weeks later, patient allegedly developed an ¿infection¿ in one of their cheeks.Patient is ¿not happy.¿ hcp reported ¿it did have some swelling and redness, but [they] didn't think it was an infection.Usually an infection would occur within 48-72hrs after a procedure, not 6 weeks.At 6 weeks, [they] put [the patient] on antibiotics (bactrim).¿ hcp told the patient to follow up 3-days later.Patient didn't come back for 2 weeks, which is when hcp administered hyaluronidase (about 2 months after the procedure).¿warmth¿ was also reported.A culture was done; results indicated no wbcs or bacteria.A ct scan without contrast was done and there was no fluid collection to suggest abscess.Hcp also recommended motrin as treatment and also provided incision and drainage.Symptoms resolved and patient was left with ¿scarring, loss of volume, and hyperpigmentation.¿.
|